CHONDRONEST Company
ChondroNest is developing the application of this intellectual property for the reconstruction of Hyaline cartilage. They are aiming to conduct preclinical tests on animal models for two indications, the Osteochondritis and subsequently the Osteoarthrosis.
After the first in-man preclinical trials the product will be licensed to major MedTech companies for sales and marketing while they will retain the production of ChondroNest™ pastes.
Founded Date:
2015-01-01
Employee Number:
1-10
Headquarters:
Conthey, Valais, Switzerland, Europe
Industry:
Implants & Prosthetics
Super Industry:
MedTech & Devices
Investors:
MassChallenge
Ipo Status:
private
City:
Conthey
Region:
Valais
Country:
Switzerland